Company Overview and News

51
Lithium Junior Miner News For The Month Of June 2018

2018-06-27 seekingalpha
Lithium market news: Joe Lowry significantly raised his new lithium demand forecast to ~800K MT LCE in 2025. Indian State-owned firms mandated to acquire overseas lithium and cobalt.
NI LIT CXO SAV LAXXF LIACF CYDVF AGY PFFOF WML POR ABEPF SQM MLNLF AVLNF AIS.H KDR SYA STLHF WMLLF LNRDY HMGLF PEMIF ABE NGZ LMMFF GXY LRS MNIKF PLU HNR AMLM 9984 AVL ALB DMNXF MALRY EEYMF SFTBF MIN NMKEF ARYMF LKE DDXFF MGXMF PLUUF DJIFF NMX PSC EMH CRECF ERPNF SFTBY PLS NNO DJI PDDTF NTTHF NNOMF CYP MALRF ORE AVZ AJM

0
Argosy reveals maiden JORC resource for Rincon lithium project

2018-06-19 australianmining.com.au
Argosy Minerals has revealed the maiden JORC 2012 mineral resource estimate for its Rincon lithium project in the Salta Province, Argentina, which includes inferred resources of 207,957 tonnes of lithium carbonate equivalent (LCE).
AGY ARYMF

0
Argosy Minerals reveals maiden lithium resource at Rincon

2018-06-19 proactiveinvestors.com.au
Argosy Minerals Ltd (ASX:AGY) has estimated a maiden JORC resource of 207,957 tonnes of lithium carbonate equivalent (LCE) within the brine aquifers of its Rincon Lithium Project.
AGY ARYMF

0
Argosy Minerals switches on gas at lithium pilot plant

2018-06-18 proactiveinvestors.com.au
Argosy Minerals Ltd (ASX:AGY) has had its mains gas supply authorised and is now in use at its stage I industrial-scale pilot plant for the Rincon Lithium Project in Argentina.
AGY ARYMF

0
Argosy Minerals produces first batch of lithium carbonate at Rincon Lithium Project

2018-06-05 proactiveinvestors.com.au
Argosy Minerals Limited (ASX:AGY) has achieved a significant milestone for its Rincon Lithium Project in Argentina by producing the first batch of lithium carbonate (LCE) from the stage 1 industrial scale pilot plant.
AGY ARYMF

0
Argosy produces first lithium batch from Rincon project

2018-06-05 australianmining.com.au
Argosy Minerals has reached a major project milestone by producing its first batch of lithium carbonate (LCE) from the Rincon lithium project in the province of Salta, Argentina.
AGY ARYMF

0
Argosy Minerals enters trading halt ahead of first lithium carbonate production

2018-06-01 proactiveinvestors.com.au
Argosy Minerals Ltd (ASX:AGY) has been granted a trading halt by the ASX pending the release of details regarding the first lithium carbonate production from its Rincon Lithium Project, Argentina.
AGY ARYMF

0
Argosy Minerals purchases mining tenements for future lithium brine operation

2018-05-28 proactiveinvestors.com.au
Argosy Minerals Ltd (ASX:AGY) has executed purchase agreements for mining titles that make up the 2,572-hectare Rincon Lithium Project in Argentina.
AGY ARYMF

0
Argosy’s maiden Rincon lithium resource imminent

2018-05-07 australianmining.com.au
Australian explorer Argosy Minerals has released an update on its in-development Rincon lithium project in Salta Province, Argentina, with a JORC resource estimate targeted for release in the next two to three weeks.
AGY ARYMF

0
Argosy Minerals expects first battery-grade lithium carbonate from pilot plant by end of May

2018-05-07 proactiveinvestors.com.au
Argosy Minerals Limited (ASX:AGY) expects to produce its first battery-grade lithium carbonate by the end of May from an industrial-scale pilot plant at the Rincon Lithium Project in Argentina.
AGY ARYMF

33
Argosy Minerals fast tracks Rincon Lithium Project to take advantage of lithium carbonate pricing

2018-05-01 proactiveinvestors.com.au
Argosy Mineral Limited’s (ASX:AGY) near-term objective is successfully proving a chemical process solution for the production of battery-grade lithium carbonate equivalent (LCE).
ALB FTI.WI FMC AGY ORE ARYMF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:AGY / ARGOSY MINERALS LIMITED on message board site Silicon Investor.

Argosy Gaming Co. (AGY) Argosy minerals, Anglo takes stake in nickel
Imagyn Medical Technologies (imti)